<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Syphilis Clinical Reference | NICE CKS</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <style>
        :root {
            --primary: #1976d2;
            --primary-light: #63a4ff;
            --primary-dark: #004ba0;
            --secondary: #00796b;
            --background: #f8f9fa;
            --surface: #ffffff;
            --text: #212121;
            --text-light: #757575;
            --border: #e0e0e0;
            --danger: #d32f2f;
            --warning: #f57c00;
            --success: #388e3c;
            --info: #0277bd;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
            background-color: var(--background);
            color: var(--text);
            line-height: 1.6;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }

        header {
            background: var(--primary);
            color: white;
            padding: 2rem 0;
            text-align: center;
            border-radius: 12px;
            margin-bottom: 2rem;
            box-shadow: 0 4px 20px rgba(25, 118, 210, 0.15);
        }

        header h1 {
            font-weight: 600;
            font-size: 2.2rem;
            margin-bottom: 0.5rem;
        }

        header p {
            font-weight: 300;
            opacity: 0.9;
            max-width: 700px;
            margin: 0 auto;
        }

        .badge {
            display: inline-block;
            background: rgba(255,255,255,0.2);
            color: white;
            padding: 4px 12px;
            border-radius: 20px;
            font-size: 0.8rem;
            margin-top: 10px;
        }

        .grid {
            display: grid;
            gap: 1.5rem;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
        }

        .card {
            background: var(--surface);
            border-radius: 12px;
            padding: 1.5rem;
            box-shadow: 0 2px 10px rgba(0,0,0,0.08);
            border: 1px solid var(--border);
            transition: transform 0.2s ease, box-shadow 0.2s ease;
        }

        .card:hover {
            transform: translateY(-4px);
            box-shadow: 0 8px 25px rgba(0,0,0,0.12);
        }

        .card h2 {
            color: var(--primary);
            font-size: 1.4rem;
            margin-bottom: 1rem;
            padding-bottom: 0.5rem;
            border-bottom: 2px solid var(--primary-light);
            display: flex;
            align-items: center;
            gap: 8px;
        }

        .card h2 i {
            font-size: 1.2rem;
        }

        .card ul {
            list-style: none;
            margin: 1rem 0;
        }

        .card ul li {
            margin: 0.7rem 0;
            padding-left: 1.2rem;
            position: relative;
        }

        .card ul li::before {
            content: "‚Ä¢";
            color: var(--primary);
            font-weight: bold;
            position: absolute;
            left: 0;
        }

        .card p {
            margin-bottom: 1rem;
            color: var(--text-light);
        }

        .tag {
            display: inline-block;
            background: var(--primary-light);
            color: white;
            padding: 2px 8px;
            border-radius: 12px;
            font-size: 0.7rem;
            margin-right: 5px;
            margin-bottom: 5px;
        }

        .alert {
            padding: 1rem;
            border-radius: 8px;
            margin: 1rem 0;
            font-size: 0.95rem;
        }

        .alert-danger {
            background-color: #ffebee;
            border-left: 4px solid var(--danger);
            color: var(--danger);
        }

        .alert-warning {
            background-color: #fff8e1;
            border-left: 4px solid var(--warning);
            color: var(--warning);
        }

        .alert-success {
            background-color: #e8f5e8;
            border-left: 4px solid var(--success);
            color: var(--success);
        }

        footer {
            text-align: center;
            margin-top: 3rem;
            padding: 2rem 0;
            color: var(--text-light);
            font-size: 0.9rem;
            border-top: 1px solid var(--border);
        }

        .btn {
            display: inline-block;
            background: var(--primary);
            color: white;
            padding: 10px 20px;
            border-radius: 6px;
            text-decoration: none;
            font-weight: 500;
            margin-top: 10px;
            transition: background 0.2s ease;
        }

        .btn:hover {
            background: var(--primary-dark);
        }

        .reference {
            font-size: 0.85rem;
            color: var(--text-light);
            font-style: italic;
            margin-top: 1rem;
        }

        @media (max-width: 768px) {
            .container {
                padding: 10px;
            }
            
            header h1 {
                font-size: 1.8rem;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>Syphilis: Clinical Reference Guide</h1>
            <p>A concise one-page algorithm for diagnosis and management in adults based on NICE CKS (March 2025)</p>
            <span class="badge">Adults ‚â•16 years | Primary Care Focus</span>
        </header>

        <div class="grid">
            <!-- When to Suspect -->
            <div class="card">
                <h2>üîç When to Suspect</h2>
                <ul>
                    <li><strong>Primary:</strong> Painless, indurated genital/oral/anal ulcer (chancre) ¬± painless lymphadenopathy (9‚Äì90 days post-exposure)</li>
                    <li><strong>Secondary:</strong> Maculopapular rash (palms/soles), condylomata lata, oral "snail tract" ulcers, patchy alopecia, generalized lymphadenopathy</li>
                    <li><strong>Latent:</strong> Asymptomatic but high-risk (MSM, multiple partners, HIV+)</li>
                    <li><strong>Tertiary:</strong> Neurological, cardiovascular, or gummatous lesions (rare)</li>
                </ul>
                <p><strong>High-risk groups:</strong> GBMSM, HIV+, socioeconomic deprivation, previous STI</p>
            </div>

            <!-- Initial Assessment -->
            <div class="card">
                <h2>üìã Initial Assessment</h2>
                <h3>History</h3>
                <ul>
                    <li>Symptoms and sexual history</li>
                    <li>Partners in last 3 months (primary) or 2 years (secondary/latent)</li>
                    <li>Prior STIs, HIV status, antenatal history</li>
                </ul>
                <h3>Examination</h3>
                <ul>
                    <li>Genital, oral, skin (palms/soles, scalp)</li>
                    <li>Neurological and ocular exam</li>
                    <li>Look for chancres, rash, condylomata lata, lymphadenopathy</li>
                </ul>
            </div>

            <!-- Immediate Action -->
            <div class="card">
                <h2>üö® Immediate Action</h2>
                <div class="alert alert-success">
                    <strong>Refer all suspected cases to GUM/sexual health clinic</strong>
                </div>
                <ul>
                    <li>Specialist testing (serology, PCR, dark-field)</li>
                    <li>Full STI screen (chlamydia, gonorrhoea, HIV, Hep B/C)</li>
                    <li>Partner notification</li>
                    <li>Expert interpretation and follow-up</li>
                </ul>
                <p><strong>Explain:</strong> Avoid all sexual contact until diagnosis/treatment confirmed.</p>
                <a href="https://www.nhs.uk/conditions/syphilis/" class="btn" target="_blank">Patient Info (NHS)</a>
            </div>

            <!-- Testing if Refusal -->
            <div class="card">
                <h2>üß™ If Patient Refuses Referral</h2>
                <p>Discuss with GUM specialist. Consider primary care testing:</p>
                <ul>
                    <li><strong>Swab lesion:</strong> PCR (preferred) or dark-field microscopy</li>
                    <li><strong>Serology:</strong> Treponemal (EIA/CLIA) and non-treponemal (RPR) tests</li>
                    <li><strong>HIV test</strong> (mandatory)</li>
                </ul>
                <div class="alert alert-warning">
                    Any positive test ‚Üí Strongly recommend GUM referral
                </div>
                <p><strong>Repeat serology:</strong> 3 months after exposure or 2 weeks after chancre resolves if initial tests negative.</p>
            </div>

            <!-- Neurosyphilis -->
            <div class="card">
                <h2>üß† Neurosyphilis Suspicion?</h2>
                <div class="alert alert-danger">
                    Refer urgently if neurological or ocular symptoms present
                </div>
                <ul>
                    <li>Headache, vision/hearing loss, cranial nerve palsies</li>
                    <li>Ocular involvement (uveitis, optic neuropathy)</li>
                    <li>Stroke in young person with syphilis risk</li>
                </ul>
                <p><strong>Diagnosis requires:</strong> CSF examination (cell count, protein, VDRL) + serology.</p>
            </div>

            <!-- Key Points -->
            <div class="card">
                <h2>üîë Key Points</h2>
                <ul>
                    <li>Syphilis is curable with early treatment</li>
                    <li>Untreated: 25% develop secondary; ~1/3 progress to tertiary (20‚Äì40 yrs)</li>
                    <li>HIV co-infection: Higher risk of neuro/ocular syphilis and reinfection</li>
                    <li>Partner notification is essential ‚Äî GUM teams manage this</li>
                    <li>Reckless transmission may be prosecutable (CPS, 2023)</li>
                </ul>
                <span class="tag">Curable</span>
                <span class="tag">STI</span>
                <span class="tag">HIV co-infection</span>
            </div>

            <!-- NICE Quality Standards -->
            <div class="card">
                <h2>üéØ NICE Quality Standards (QS178)</h2>
                <ul>
                    <li>Ask about sexual history at key contacts</li>
                    <li>Offer STI testing to at-risk individuals</li>
                    <li>MSM at increased risk: repeat testing every 3 months</li>
                    <li>Partner notification support for all diagnosed STIs</li>
                </ul>
                <p class="reference">[NICE, 2022]</p>
            </div>

            <!-- Prevalence -->
            <div class="card">
                <h2>üìä UK Prevalence (2023)</h2>
                <ul>
                    <li><strong>12,588</strong> new diagnoses</li>
                    <li><strong>76%</strong> among GBMSM</li>
                    <li><strong>53%</strong> of GBMSM cases in London</li>
                    <li>Rising rates in heterosexuals (+203% women, +126% men)</li>
                    <li>Disproportionate in socioeconomically deprived areas</li>
                </ul>
                <p class="reference">[UKHSA, 2024]</p>
            </div>
        </div>

        <footer>
            <p>Based on NICE CKS guidance for Syphilis (March 2025 revision) | For adults ‚â•16 years</p>
            <p>Excludes congenital syphilis, screening, and pregnancy management</p>
            <p>Refer to full NICE CKS guidance for treatment regimens and follow-up protocols</p>
        </footer>
    </div>
</body>
</html>